http://investors.axovant.com/static-files/e32602ff-0d42-4bbe-9041-a1b56176940a
Dream team of gene therapy veterens on page 5.
"AXO-AAV-OPMD program is the first gene therapy using Silence-and-Replace technology in a single vector to enter the clinic • Delivers a combination of DNA-directed RNA interference (Silence) along with a functional copy of the gene (Replace)" Page 27